Invenomic Fund Institutional Class shares
BIVIX
NASDAQ
| Weiss Ratings | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C- | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Company Info | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Invenomic | |||
| Manager/Tenure (Years) | Benjamin R. Deschaine (8), Ali Motamed (8) | |||
| Website | http://www. invenomic.com | |||
| Fund Information | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Invenomic Fund Institutional Class shares | |||
| Category | Long-Short Equity | |||
| Sub-Category | Long/Short Equity | |||
| Prospectus Objective | Growth | |||
| Inception Date | Jun 19, 2017 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 50,000.00 | |||
| Minimum Subsequent Investment | 500.00 | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 2.13% | |||
| Dividend | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.93% | |||
| Asset Allocation | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 80.63% | |||
| Stock | 19.37% | |||
| U.S. Stock | 15.27% | |||
| Non-U.S. Stock | 4.10% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.44% | |||
| 30-Day Total Return | 4.95% | |||
| 60-Day Total Return | 1.69% | |||
| 90-Day Total Return | 5.62% | |||
| Year to Date Total Return | 1.69% | |||
| 1-Year Total Return | 5.86% | |||
| 2-Year Total Return | 7.89% | |||
| 3-Year Total Return | 3.90% | |||
| 5-Year Total Return | 122.17% | |||
| Price | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $18.00 | |||
| 1-Month Low NAV | $16.69 | |||
| 1-Month High NAV | $18.29 | |||
| 52-Week Low NAV | $15.99 | |||
| 52-Week Low NAV (Date) | Nov 03, 2025 | |||
| 52-Week High NAV | $18.60 | |||
| 52-Week High Price (Date) | Mar 10, 2025 | |||
| Beta / Standard Deviation | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.32 | |||
| Standard Deviation | 13.34 | |||
| Balance Sheet | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.07B | |||
| Operating Ratios | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 3.17% | |||
| Turnover Ratio | 197.00% | |||
| Performance | BIVIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | -5.81% | |||
| Last Bear Market Total Return | 5.95% | |||